Bayer HealthCare announced the acquisition of Maxygen's (NASDAQ: MAXY) hemophilia program assets, including a next-generation recombinant ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE